Skip to main content
. 2022 Oct 26;12:997093. doi: 10.3389/fonc.2022.997093

Figure 4.

Figure 4

Kaplan-Meier analysis of time to recurrence according to (A) VETC-positive vs. VETC-negative patients and (B) number of VETC-positive tumors; and Kaplan-Meier analysis of recurrence-free survival according to (C) VETC-positive vs. VETC-negative patients and (D) number of VETC-positive tumors in patients with HCC receiving LT. HCC, hepatocellular carcinoma; VETC, vessels that encapsulate tumor clusters.